Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 2
2007 1
2009 1
2010 1
2011 4
2012 6
2013 4
2014 8
2015 8
2016 11
2017 16
2018 19
2019 18
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 31530690

101 results
Results by year
Filters applied: . Clear all
Page 1
Management of type 2 diabetes: now and the future.
Edeghere S, English P. Edeghere S, et al. Clin Med (Lond). 2019 Sep;19(5):403-405. doi: 10.7861/clinmed.2019-0318. Clin Med (Lond). 2019. PMID: 31530690 Free PMC article.
EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.
Schernthaner G, Schernthaner-Reiter MH, Schernthaner GH. Schernthaner G, et al. Clin Ther. 2016 Jun;38(6):1288-1298. doi: 10.1016/j.clinthera.2016.04.037. Epub 2016 May 19. Clin Ther. 2016. PMID: 27210264
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
Thrasher J. Thrasher J. Am J Med. 2017 Jun;130(6S):S4-S17. doi: 10.1016/j.amjmed.2017.04.004. Am J Med. 2017. PMID: 28526182 Free article. Review.
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B, Sonne DP, Metzendorf MI, Richter B. Hemmingsen B, et al. Cochrane Database Syst Rev. 2016 Oct 17;10(10):CD012151. doi: 10.1002/14651858.CD012151.pub2. Cochrane Database Syst Rev. 2016. PMID: 27749986 Free PMC article. Review.
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
Thrasher J. Thrasher J. Am J Cardiol. 2017 Jul 1;120(1S):S4-S16. doi: 10.1016/j.amjcard.2017.05.009. Epub 2017 May 30. Am J Cardiol. 2017. PMID: 28606343 Free article. Review.
Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Madsen KS, Chi Y, Metzendorf MI, Richter B, Hemmingsen B. Madsen KS, et al. Cochrane Database Syst Rev. 2019 Dec 3;12(12):CD008558. doi: 10.1002/14651858.CD008558.pub2. Cochrane Database Syst Rev. 2019. PMID: 31794067
Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B, Sonne DP, Metzendorf MI, Richter B. Hemmingsen B, et al. Cochrane Database Syst Rev. 2017 May 10;5(5):CD012204. doi: 10.1002/14651858.CD012204.pub2. Cochrane Database Syst Rev. 2017. PMID: 28489279 Free PMC article. Review.
Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL, Figgitt DP. Plosker GL, et al. Pharmacoeconomics. 2004;22(6):389-411. doi: 10.2165/00019053-200422060-00005. Pharmacoeconomics. 2004. PMID: 15099124 Review.
Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes.
Handelsman Y. Handelsman Y. Adv Ther. 2019 Oct;36(10):2567-2586. doi: 10.1007/s12325-019-01054-w. Epub 2019 Aug 23. Adv Ther. 2019. PMID: 31444707 Free PMC article. Review.
The elephant in the room: Why cardiologists should stop ignoring type 2 diabetes.
O'Keefe JH, Nassif ME, Magwire ML, O'Keefe EL, Lavie CJ. O'Keefe JH, et al. Prog Cardiovasc Dis. 2019 Jul-Aug;62(4):364-369. doi: 10.1016/j.pcad.2019.08.001. Epub 2019 Aug 10. Prog Cardiovasc Dis. 2019. PMID: 31408637 Review.
101 results
Jump to page
Feedback